Galderma Laboratories has awarded agency of record for advertising and promotion for three products in the corrective and aesthetic market to Brand Pharm, a member of the Publicis Healthcare Communications Group of agencies. Two of the products – Pliaglistm (7% lidocaine/7 % tetracaine), a topical anesthetic, and Elevesstm, a cosmetic filler – are new products. The third product – Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%), a treatment for melasma, a hyperpigmentation disorder – was already a Brand Pharm assignment for medical promotions. These new assignments increase the total to five products the agency’s assignments with Galderma. Brand Pharm has had the agency assignment for Differin (adapalene), a prescription treatment for acne, and Metrogel (metronidazole gel, 1%), one of the leading therapies prescribed by dermatologists for rosacea.
Account wins
Galderma Laboratories has awarded agency of record for advertising and promotion for three products in the corrective and aesthetic market to Brand Pharm, a member of the Publicis Healthcare Communications Group of agencies.